Kiran Mazumdar Shaw’s multi-billion dollar baby
Biocon Biologics’ valuation has raised eyebrows. But the parent has strong growth on its side and a track record of solid execution
Kripa Mahalingam - April 25, 2020
Bed, Set, Go
Now that Apollo Hospitals’ aggressive capex is done, analysts believe it is time to buy the stock
Kripa Mahalingam - March 07, 2020
Will HDFC Bank continue to outperform its peers?
The marquee lender is battling to grow its book amidst slowing economic growth
November 01, 2019
On Solid Ground
Shree Cement has had spectacular success in the North. Can it conquer the South and East?
Krishna Gopalan - May 03, 2017
The Power Of Small
Here’s why small finance banks may not only help serve the unbanked rural population but also ensure credit growth
Rajat Ubhaykar - April 27, 2016
Back On The Road Again
The government is accelerating road projects when most players have buckled under the pressure of excessive leverage. Should you bet on the last men standing?
Jitendra Kumar Gupta - March 23, 2016
Lafarge, you are too large
Competition Commission finds LafargeHolcim's eastern India spread discomforting
Krishna Gopalan - February 12, 2016
Not so fast
Slow growth and high valuations seem to be making investors wary of FMCG stocks
Jash Kriplani - November 24, 2015
Who do you think is buying?
High delivery volume is worrisome or positive depending on your market view
Jitendra Kumar Gupta - September 11, 2015